Scientists have been given the go-ahead to create 3,000 doses of a new potentially groundbreaking lung cancer vaccine for people at high risk of the disease.
Experts at the University of Oxford and the Francis Crick Institute and University College in London are using technology similar to that used in the Oxford-AstraZeneca vaccine which was rolled out to combat the spread of Covid.
